Coriolis Pharma | Biopharmaceutical research & development service

Coriolis Pharma Your partner for formulation development, analytical services and Non-GMP manufacturing

We enable the development of innovative drugs by performing outstanding biopharmaceutical research to improve the quality of life for humankind.

About us

Coriolis Pharma is a globally operating contract research organization and a leader in formulation research and development of biopharmaceutical drugs, including cell and gene therapy products and vaccines .

We offer early and late-stage formulation development for liquid and lyophilized drug products, lyophilization process development, analytical method development under R&D and GMP and Non-GMP manufacturing for a wide range of products.

Our latest news & updates

Publication

Characterization of Virus Particles and Submicron-Sized Particulate Impurities in Recombinant Adeno-Associated Virus Drug Product

Cornelia Hiemenz, Anabel Pacios-Michelena, Constanze Helbig, Valerija Vezočnik, Michael Strebl, Felix Nikels, Andrea Hawe, Patrick Garidel, Tim Menzen

Upcoming Event

2023/05/10

Visit us in the German Pavilion at BIO 2023

We are looking forward to meeting you in the German Pavilion at BIO 2023 in Boston. Meet our experts Evelyn Eggenstein and Michael Wiggenhorn (Board Director) at booth 1335-01.

Publication

A model-based optimization strategy to achieve fast and robust freeze-drying cycles

Brecht Vanbillemont, Anna-Lena Greiner, Vanessa Ehrl, Tim Menzen, Wolfgang Friess, Andrea Hawe

Webinar

Live

2023/07/05 - 16:00 (CEST)

AUC – A real alternative for characterization and QC analysis of biologics, vaccines and gene therapy vectors?

Dr. Klaus Richter will talk about analytical ultracentrifugation as an alternative to traditional methods for characterization and QC analysis.

Webinar

Live

2023/10/11 - 16:00 (CEST)

Protecting viral vectors - Why we need a formulation development program

Our scientific advisor, Prof. Dr. Gideon Kersten will give you insights in the chances of lyophilized formulations and the analytical challenges for viral vectors

Webinar

Live

2023/11/29 - 16:00 (CET)

Every particle matters - identify visible and subvisible particles in your biologic and gene and cell therapy drug product

Tim Menzen and Daniel Demminger will explain how to identify and characterize visible and sub-visible particles in biologics or gene and cell therapy products

News

2023/02/01

Coriolis Pharma appoints formulation expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board

With the appointment of Reza Nejadnik to its scientific advisory board, Coriolis again strengthens its scientific expertise particularly in the area of protein formulation and analytics.

Publication

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

Hristo L. Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni

Publication

SV-AUC as a stability-indicating method for the characterization of mRNA-LNPs

Anian Thaller, Lukas Schmauder, Wolfgang Frieß, Gerhard Winter, Tim Menzen, Andrea Hawe, Klaus Richter

News

2022/12/06

Press Release: Bruce Kerwin

Coriolis Pharma appoints formulation and drug development expert Bruce Kerwin to scientific advisory board

View all news updates

Select your product type

Each biopharmaceutical compound is unique and deserves special attention from an expert partner. Thanks to our established knowhow, we tailor our development and analytical services to your specific needs. Select your product type and explore our portfolio of flexible and science-driven solutions tailored to the needs of your product and development phase.

Your product

Antibody or related product

Get to know Coriolis

Speak to our experts and learn how you can benefit from our high quality services

Get in contact

We are your partner with scientific excellence

Coriolis provides high-quality research, development, and analytical services from discovery phase to and beyond market approval. Our strategy is to generate innovation by combining technologies, knowledge, and experience. In a collaborative partnership with our clients, we develop innovative drugs to improve the quality of life for humankind.

Development services

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert partner in developing liquid and lyophilized drug products for a large variety of different (bio)pharmaceutical molecules, including proteins, peptides, nucleic acids, ATMPs, GMOs, vaccines and virus(-like) particles.

Find out how we can support your drug development!

Analytical services

A highly diverse portfolio of in-house analytical techniques: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field. We provide analytical services for samples up to biosafety level S2 under R&D and GMP conditions, including method development, qualification, and validation.

Get to know our services

Let's talk!

Get to know Coriolis, speak with our experts about your request and learn how you can benefit from our high quality services.

Get in contact

Feedback from clients

Coriolis has a long track record in performing outstanding biopharmaceutical research for clients all over the globe. We have successfully supported numerous development projects for a large variety of biopharmaceutical molecules. Our clients value the scientific expertise of our project teams and the flexibility in designing tailored formulation development programs. But listen for yourself, what our clients have to say:

“You have accomplished an extraordinary amount of difficult work for the project in a very limited period of time. This is much appreciated given the demanding timelines and challenges associated with this project.”

Project manager Global R&D | Mid-sized biotech | Europe | Formulation development

“Excellent lab work, highly motivated and dedicated team.”

Project manager | Big-Pharma | Europe | Formulation development

“Thank you very much for the data, the results are just what we needed! This was invaluable and we look forward to working with you again in the future on this and other targets. Thank you again very much for your work.”

Scientist | Small biotech | USA | Analytical service

“Very appreciate for your good effort, your rich experiences and achieving good results in our project this year.”

QC-manager | Mid-sized Pharma | Asia | Biosimilar comparability

“Exactly the results we were looking for, we really enjoyed working with you, we will come back for further studies”

Senior Director Product Development | Mid-sized Pharma | Europe | In-use stability

Our facts & figures

14+

years of experience

200+

highly qualified employees

130+

peer-reviewed scientific publication

725+

global client from start-up to big-pharma

1500+

projects performed successfully

780+

different drug substances

130+

formulations for clinical products developed

14+

commercial products supported

Contact us

Do you have any questions?
Want to submit or discuss a service request?
We are happy to help!

Click here to contact our experts today